Evidence map›Paper›PMID 32997191›Full record

ReviewAnnals of hematology2021

Central venous catheter-related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Boris Böll, Enrico Schalk, Dieter Buchheidt, Justin Hasenkamp, Michael Kiehl, Til Ramon Kiderlen, Matthias Kochanek, Michael Koldehoff, Philippe Kostrewa, Annika Y Claßen and 9 more

Open access · hybridAbstract readReview
In one paragraph

Review in Annals of hematology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 3 pooled it
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 3 syntheses or guidelines pooled it, 143 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Catheter-related complications in AML remission induction chemotherapy: a retrospective comparison of PICCs and CICCs.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  6. Review
  7. Perioperative considerations for patients with multiple myeloma.European journal of anaesthesiology and intensive care · 2026
    Review
  8. Susceptibility ofAntibiotics (Basel, Switzerland) · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. [S1 guideline on sustainability in intensive care and emergency medicine].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2025
    Review
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 14 institutions in 2 countries.

Boris BöllDepartment I of Internal Medicine, Hematology and Oncology, Intensive Care Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Kerpener Strasse 62, 50937, Cologne, Germany. boris.boell@uk-koeln.de.ORCID https://orcid.org/0000-0002-6432-0981
Enrico SchalkDepartment of Hematology and Oncology, Otto-von-Guericke University Magdeburg, Medical Center, Magdeburg, Germany.
Dieter BuchheidtDepartment of Hematology and Oncology, Mannheim University Hospital, Heidelberg University, Mannheim, Germany.
Justin HasenkampClinic for Hematology and Oncology, University Medicine Göttingen, Georg-August-University, Göttingen, Germany.
Michael KiehlDepartment of Internal Medicine, Frankfurt (Oder) General Hospital, Frankfurt/Oder, Germany.
Til Ramon KiderlenDepartment of Hematology, Oncology and Palliative Care, Vivantes Clinic Neukoelln, Berlin, Germany.
Matthias KochanekDepartment I of Internal Medicine, Hematology and Oncology, Intensive Care Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Kerpener Strasse 62, 50937, Cologne, Germany.
Michael KoldehoffDepartment of Bone Marrow Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Philippe KostrewaDepartment of Hematology and Oncology, Campus Fulda, Philipps-University Marburg, Fulda, Germany.
Annika Y ClaßenDepartment I of Internal Medicine, Hematology and Oncology, Intensive Care Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Kerpener Strasse 62, 50937, Cologne, Germany.
Sibylle C MellinghoffDepartment I of Internal Medicine, Hematology and Oncology, Intensive Care Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Kerpener Strasse 62, 50937, Cologne, Germany.
Bernd MetznerDepartment of Hematology and Oncology, University Hospital Oldenburg, Oldenburg, Germany.
Olaf PenackDepartment of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Markus RuhnkeDepartment of Hematology and Oncology, Helios Klinikum Aue, Aue, Germany.
Maria J G T VehreschildDepartment of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany.
Florian WeissingerDepartment of Hematology, Oncology and Palliative Care, Department of Internal Medicine, Evangelisches Klinikum Bethel, Bielefeld, Germany.
Hans-Heinrich WolfDepartment III of Internal Medicine, Hematology, Oncology and Hemostaseology, Südharzklinikum, Nordhausen, Germany.
Meinolf KarthausDepartment of Hematology, Oncology & Palliative Care, Klinikum Neuperlach, Munich, Germany.
Marcus HentrichDepartment of Hematology and Oncology, Red Cross Hospital Munich, Munich, Germany.
University of Cologne · DEGoethe University Frankfurt · DECharité - Universitätsmedizin Berlin · DEEvangelisches Krankenhaus Bielefeld · DEFulda University of Applied Sciences · DEGerman Red Cross · DEHeidelberg University · DEHelios Vogtland Klinikum Plauen · DEKlinikum Oldenburg · DEMünchen Klinik Neuperlach · DEOtto-von-Guericke-Universität Magdeburg · DESüdharz Klinikum · DEUniversity of Duisburg-Essen · DEVivantes Klinikum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer patients frequently require central venous catheters for therapy and parenteral nutrition and are at high risk of central venous catheter-related infections (CRIs). Moreover, CRIs prolong hospitalization, cause an excess in resource utilization and treatment cost, often delay anti-cancer treatment, and are associated with a significant increase in mortality in cancer patients. We therefore summoned a panel of experts by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO) and updated our previous guideline on CRIs in cancer patients. After conducting systematic literature searches on PubMed, Medline, and Cochrane databases, video- and meeting-based consensus discussions were held. In the presented guideline, we summarize recommendations on definition, diagnosis, management, and prevention of CRIs in cancer patients including the grading of strength of recommendations and the respective levels of evidence. This guideline supports clinicians and researchers alike in the evidence-based decision-making in the management of CRIs in cancer patients.

Indexed as

Catheter-Related InfectionsCentral Venous CathetersCommunicable DiseasesDisease ManagementGermanyHematologic NeoplasmsHematologyHumansMedical OncologyPractice Guidelines as TopicSocieties, MedicalCancerCatheter infectionCentral venous catheterCLABSICRBSINeutropenia

Identifiers

PMID32997191
PMCPMC7782365
OpenAlexW3091736381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.